711 related articles for article (PubMed ID: 33647418)
1. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
2. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
3. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
4. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
5. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
6. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets.
Sadia M; Arafat B; Ahmed W; Forbes RT; Alhnan MA
J Control Release; 2018 Jan; 269():355-363. PubMed ID: 29146240
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and
Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
[TBL] [Abstract][Full Text] [Related]
8. 3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies.
Ibrahim M; Barnes M; McMillin R; Cook DW; Smith S; Halquist M; Wijesinghe D; Roper TD
AAPS PharmSciTech; 2019 May; 20(5):195. PubMed ID: 31119403
[TBL] [Abstract][Full Text] [Related]
9. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms.
McDonagh T; Belton P; Qi S
Eur J Pharm Biopharm; 2022 Aug; 177():113-125. PubMed ID: 35779743
[TBL] [Abstract][Full Text] [Related]
11. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
12. Investigations of process parameters during dissolution studies of drug loaded 3D printed tablets.
Sharma V; Shaik KM; Choudhury A; Kumar P; Kala P; Sultana Y; Shukla R; Kumar D
Proc Inst Mech Eng H; 2021 May; 235(5):523-529. PubMed ID: 33570013
[TBL] [Abstract][Full Text] [Related]
13. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
14. 3D-printed tablets using a single-step hot-melt pneumatic process for poorly soluble drugs.
Kim SJ; Lee JC; Ko JY; Lee SH; Kim NA; Jeong SH
Int J Pharm; 2021 Feb; 595():120257. PubMed ID: 33486029
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing.
Hoffmann L; Breitkreutz J; Quodbach J
Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059
[TBL] [Abstract][Full Text] [Related]
16. Speed it up, slow it down…An issue of bicalutamide release from 3D printed tablets.
Jamróz W; Kurek M; Szafraniec-Szczęsny J; Czech A; Gawlak K; Knapik-Kowalczuk J; Leszczyński B; Wróbel A; Paluch M; Jachowicz R
Eur J Pharm Sci; 2020 Feb; 143():105169. PubMed ID: 31785383
[TBL] [Abstract][Full Text] [Related]
17. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
[TBL] [Abstract][Full Text] [Related]
18. Predicting drug release from diazepam FDM printed tablets using deep learning approach: Influence of process parameters and tablet surface/volume ratio.
Obeid S; Madžarević M; Krkobabić M; Ibrić S
Int J Pharm; 2021 May; 601():120507. PubMed ID: 33766640
[TBL] [Abstract][Full Text] [Related]
19. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.
Serajuddin ATM
ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904
[TBL] [Abstract][Full Text] [Related]
20. Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.
Wei C; Solanki NG; Vasoya JM; Shah AV; Serajuddin ATM
J Pharm Sci; 2020 Apr; 109(4):1558-1572. PubMed ID: 32004538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
